Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
50
BME Quote, Financials, Valuation and Earnings
Last price:
$36.54
Seasonality move
:
2.65%
Day range:
$37.24 - $37.55
52-week range:
$34.18 - $42.64
Dividend yield:
4.81%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
32.7K
Avg. volume:
47.5K
1-year change:
-5.66%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
$37.37 | -- | -- | -- | $0.26 | 4.81% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.60 | -- | -- | -- | $0.17 | 9.1% | -- |
|
HQH
abrdn Healthcare Investors
|
$16.32 | -- | -- | -- | $0.57 | 3.49% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$88.52 | -- | -- | -- | $0.62 | 1.46% | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
$19.24 | -- | -- | -- | $0.18 | 5.61% | -- |
|
THW
Tekla World Healthcare Fund
|
$10.98 | -- | -- | -- | $0.12 | 7.44% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | 0.994 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.556 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 1.594 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.881 | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | 1.177 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 1.152 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
Blackrock Health Sciences Trust vs. Competitors
-
Which has Higher Returns BME or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About BME or BMEZ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than BlackRock Health Sciences Trust II, analysts believe Blackrock Health Sciences Trust is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is BME or BMEZ More Risky?
Blackrock Health Sciences Trust has a beta of 0.710, which suggesting that the stock is 28.992% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 1.100, suggesting its more volatile than the S&P 500 by 10.021%.
-
Which is a Better Dividend Stock BME or BMEZ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 4.81%. BlackRock Health Sciences Trust II offers a yield of 9.1% to investors and pays a quarterly dividend of $0.17 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or BMEZ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns BME or HQH?
abrdn Healthcare Investors has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About BME or HQH?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than abrdn Healthcare Investors, analysts believe Blackrock Health Sciences Trust is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is BME or HQH More Risky?
Blackrock Health Sciences Trust has a beta of 0.710, which suggesting that the stock is 28.992% less volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.844, suggesting its less volatile than the S&P 500 by 15.628%.
-
Which is a Better Dividend Stock BME or HQH?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 4.81%. abrdn Healthcare Investors offers a yield of 3.49% to investors and pays a quarterly dividend of $0.57 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or HQH?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns BME or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About BME or IXJ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than iShares Global Healthcare ETF, analysts believe Blackrock Health Sciences Trust is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is BME or IXJ More Risky?
Blackrock Health Sciences Trust has a beta of 0.710, which suggesting that the stock is 28.992% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.707, suggesting its less volatile than the S&P 500 by 29.346%.
-
Which is a Better Dividend Stock BME or IXJ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 4.81%. iShares Global Healthcare ETF offers a yield of 1.46% to investors and pays a quarterly dividend of $0.62 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or IXJ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns BME or THQ?
abrdn Healthcare Opportunities Fund has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat abrdn Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About BME or THQ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than abrdn Healthcare Opportunities Fund, analysts believe Blackrock Health Sciences Trust is more attractive than abrdn Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 THQabrdn Healthcare Opportunities Fund0 0 0 -
Is BME or THQ More Risky?
Blackrock Health Sciences Trust has a beta of 0.710, which suggesting that the stock is 28.992% less volatile than S&P 500. In comparison abrdn Healthcare Opportunities Fund has a beta of 0.942, suggesting its less volatile than the S&P 500 by 5.791%.
-
Which is a Better Dividend Stock BME or THQ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 4.81%. abrdn Healthcare Opportunities Fund offers a yield of 5.61% to investors and pays a quarterly dividend of $0.18 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. abrdn Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or THQ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than abrdn Healthcare Opportunities Fund quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than abrdn Healthcare Opportunities Fund's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while abrdn Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for abrdn Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- --
-
Which has Higher Returns BME or THW?
Tekla World Healthcare Fund has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About BME or THW?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Tekla World Healthcare Fund, analysts believe Blackrock Health Sciences Trust is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is BME or THW More Risky?
Blackrock Health Sciences Trust has a beta of 0.710, which suggesting that the stock is 28.992% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.907, suggesting its less volatile than the S&P 500 by 9.331%.
-
Which is a Better Dividend Stock BME or THW?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 4.81%. Tekla World Healthcare Fund offers a yield of 7.44% to investors and pays a quarterly dividend of $0.12 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or THW?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 142.42% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 8.31% over the past day.
